Object. The purpose of this study was to elucidate the pathophysiological characteristics of hydrocephalus in a new transgenic model of mice created to overproduce the cytokine transforming growth factor—β1 (TGFβ1) in the central nervous system (CNS).
Methods. Galbreath and colleagues generated transgenic mice that overexpressed TGFβ1 in the CNS in an effort to examine the role of this cytokine in the response of astrocytes to injury. Unexpectedly, the animals developed severe hydrocephalus and died. The authors have perpetuated this transgenic colony to serve as a model of congenital hydrocephalus, breeding asymptomatic carrier males that are heterozygous for the transgene with wild-type females.
One hundred twelve (49.6%) of 226 mice developed clinical manifestations of hydrocephalus, characterized by dorsal doming of the calvaria, spasticity, limb tremors, ataxia, and, ultimately, death. The presence of the TGFβ1 transgene was determined by performing polymerase chain reaction (PCR) analysis of sample tail slices. Animals with the hydrocephalic phenotype consistently carried the transgene, although some animals with the transgene did not develop hydrocephalus. Animals without the transgene did not develop hydrocephalus.
Alterations in brain structure were characterized using magnetic resonance (MR) imaging, gross and light microscopic analysis, and immunocytochemical studies. Magnetic resonance imaging readily distinguished hydrocephalic animals from nonhydrocephalic controls and demonstrated an obstruction at the outlets of the fourth ventricle. Gross and light microscopic examination confirmed the MR findings. The results of immunofluorescent staining of brain tissue slices revealed the presence of the TGFβ1 cytokine and its receptor preferentially in the meninges and subarachnoid space in both hydrocephalic and control mice. Reverse transcriptase—PCR analysis demonstrated tissue-specific expression of the TGFβ1 gene in the brains of transgenic mice, and enzyme-linked immunosorbent assay confirmed overexpression of the TGFβ1 cytokine in brain, cerebrospinal fluid, and plasma.
Conclusions. The transgenic murine model provides a reproducible representation of congenital hydrocephalus. The authors hypothesize that overexpression of TGFβ1 in the CNS causes hydrocephalus by altering the environment of the extracellular matrix and interfering with the circulation of cerebrospinal fluid. A model of hydrocephalus in which the genetic basis is known should be useful for evaluating hypotheses regarding the pathogenesis of this disorder and should also help in the search for new treatment strategies.
Abe K, , Chu PJ, & Ishihara A, et al: Transforming growth factor-β1 promotes re-elongation of injured axons of cultured rat hippocampal neurons. Brain Res 723:206–209, 1996 Abe K, Chu PJ, Ishihara A, et al: Transforming growth factor-β1 promotes re-elongation of injured axons of cultured rat hippocampal neurons. Brain Res 723:206–209, 1996
Assoian RK, , Komoriya A, & Meyers CA, et al: Transforming growth factor-β in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258:7155–7160, 1983 Assoian RK, Komoriya A, Meyers CA, et al: Transforming growth factor-β in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 258:7155–7160, 1983
Ata AK, , Funa K, & Olsson Y: Expression of various TGF-β iso-forms and type I receptor in necrotizing human brain lesions. Acta Neuropathol 93:326–333, 1997 Ata AK, Funa K, Olsson Y: Expression of various TGF-β iso-forms and type I receptor in necrotizing human brain lesions. Acta Neuropathol 93:326–333, 1997
Attisano L, , Wrana JL, & Lopez-Casillas F, et al: TGF-β receptors and actions. Biochim Biophys Acta 1222:71–80, 1994 Attisano L, Wrana JL, Lopez-Casillas F, et al: TGF-β receptors and actions. Biochim Biophys Acta 1222:71–80, 1994
Bachs A, & Walker AE: Experimental hydrocephalus. J Neuropathol Exp Neurol 12:283–292, 1953 Bachs A, Walker AE: Experimental hydrocephalus. J Neuropathol Exp Neurol 12:283–292, 1953
Barcellos-Hoff MH, , Ehrhart EJ, & Kalia M, et al: Immunohistochemical detection of active transforming growth factor-β in situ using engineered tissue. Am J Pathol 147:1228–1237, 1995 Barcellos-Hoff MH, Ehrhart EJ, Kalia M, et al: Immunohistochemical detection of active transforming growth factor-β in situ using engineered tissue. Am J Pathol 147:1228–1237, 1995
Becker DP, , Wilson JA, & Watson GW: The spinal cord central canal: response to experimental hydrocephalus and canal occlusion. J Neurosurg 36:416–424, 1972 Becker DP, Wilson JA, Watson GW: The spinal cord central canal: response to experimental hydrocephalus and canal occlusion. J Neurosurg 36:416–424, 1972
Bering EA Jr, & Sato O: Hydrocephalus: changes in formation and absorption of cerebrospinal fluid within the cerebral ventricles. J Neurosurg 20:1050–1063, 1963 Bering EA Jr, Sato O: Hydrocephalus: changes in formation and absorption of cerebrospinal fluid within the cerebral ventricles. J Neurosurg 20:1050–1063, 1963
Blount JP, , Campbell JA, & Haines SJ: Complications in ventricular cerebrospinal fluid shunting. Neurosurg Clin North Am 4:633–656, 1993 Blount JP, Campbell JA, Haines SJ: Complications in ventricular cerebrospinal fluid shunting. Neurosurg Clin North Am 4:633–656, 1993
Bondurant CP, & Jimenez DF: Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg 23:254–259, 1995 Bondurant CP, Jimenez DF: Epidemiology of cerebrospinal fluid shunting. Pediatr Neurosurg 23:254–259, 1995
Border WA, & Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286–1292, 1994 Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286–1292, 1994
Border WA, , Noble NA, & Yamamoto T, et al: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361–364, 1992 Border WA, Noble NA, Yamamoto T, et al: Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 360:361–364, 1992
Border WA, , Okuda S, & Languino LR, et al: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371–374, 1990 Border WA, Okuda S, Languino LR, et al: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346:371–374, 1990
Border WA, & Ruoslahti E: Transforming growth factor-β1 in disease: the dark side of tissue repair. J Clin Invest 90:1–7, 1992 Border WA, Ruoslahti E: Transforming growth factor-β1 in disease: the dark side of tissue repair. J Clin Invest 90:1–7, 1992
Borit A, & Sidman RL: New mutant mouse with communicating hydrocephalus and secondary aqueductal stenosis. Acta Neuropathol 21:316–331, 1972 Borit A, Sidman RL: New mutant mouse with communicating hydrocephalus and secondary aqueductal stenosis. Acta Neuropathol 21:316–331, 1972
Brand T, & Schneider MD: Inactive type II and type I receptors for TGFβ are dominant inhibitors of TGFβ-dependent transcription. J Biol Chem 270:8274–8284, 1995 Brand T, Schneider MD: Inactive type II and type I receptors for TGFβ are dominant inhibitors of TGFβ-dependent transcription. J Biol Chem 270:8274–8284, 1995
Brenner M, , Kisseberth WC, & Su Y, et al: GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 14:1030–1037, 1994 Brenner M, Kisseberth WC, Su Y, et al: GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 14:1030–1037, 1994
Brinster RL, , Chen HY, & Trumbauer ME, et al: Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci USA 82:4438–4442, 1985 Brinster RL, Chen HY, Trumbauer ME, et al: Factors affecting the efficiency of introducing foreign DNA into mice by microinjecting eggs. Proc Natl Acad Sci USA 82:4438–4442, 1985
Brunner AM, , Marquardt H, & Malacko AR, et al: Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β1 precursor. Expression and characterization of mutant proteins. J Biol Chem 264:13660–13664, 1989 Brunner AM, Marquardt H, Malacko AR, et al: Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β1 precursor. Expression and characterization of mutant proteins. J Biol Chem 264:13660–13664, 1989
Casey A, , Kimmings E, & Kleinlugtebeld A, et al: The long-term outlook for hydrocephalus in childhood. Pediatr Neurosurg 27:63–70, 1997 Casey A, Kimmings E, Kleinlugtebeld A, et al: The long-term outlook for hydrocephalus in childhood. Pediatr Neurosurg 27:63–70, 1997
Casmiro M, , Benassi G, & Cacciatore FM, et al: Frequency of idiopathic normal pressure hydrocephalus. Arch Neurol 46:608, 1989 (Letter) Casmiro M, Benassi G, Cacciatore FM, et al: Frequency of idiopathic normal pressure hydrocephalus. Arch Neurol 46:608, 1989 (Letter)
Chumas PD, , Drake JM, & Del Bigio MR, et al: Anaerobic glycolysis preceding white-matter destruction in experimental neonatal hydrocephalus. J Neurosurg 80:491–501, 1994 Chumas PD, Drake JM, Del Bigio MR, et al: Anaerobic glycolysis preceding white-matter destruction in experimental neonatal hydrocephalus. J Neurosurg 80:491–501, 1994
Constam DB, , Philipp J, & Malipiero UV, et al: Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblasoma cells, astrocytes, and microglia. J Immunol 148:1404–1410, 1992 Constam DB, Philipp J, Malipiero UV, et al: Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblasoma cells, astrocytes, and microglia. J Immunol 148:1404–1410, 1992
Creange A, , Belec L, & Clair B, et al: Circulating transforming growth factor beta 1 (TGF-β1) in Guillain-Barre syndrome: decreased concentrations in the early course and increase with motor function. J Neurol Neurosurg Psychiatry 64:162–165, 1998 Creange A, Belec L, Clair B, et al: Circulating transforming growth factor beta 1 (TGF-β1) in Guillain-Barre syndrome: decreased concentrations in the early course and increase with motor function. J Neurol Neurosurg Psychiatry 64:162–165, 1998
Dandy WE, & Blackfan KD: Internal hydrocephalus. An experimental, clinical and pathological study. Am J Dis Child 8:406–482, 1914 Dandy WE, Blackfan KD: Internal hydrocephalus. An experimental, clinical and pathological study. Am J Dis Child 8:406–482, 1914
Danielpour D, , Kim KY, & Dart LL, et al: Sandwich enzymelinked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGFbeta 1 and TGF-beta 2) in complex biological fluids. Growth Factors 2:61–71, 1989 Danielpour D, Kim KY, Dart LL, et al: Sandwich enzymelinked immunosorbent assays (SELISAs) quantitate and distinguish two forms of transforming growth factor-beta (TGFbeta 1 and TGF-beta 2) in complex biological fluids. Growth Factors 2:61–71, 1989
Davidoff LM: Treatment of hydrocephalus. Historical review and description of a new method. Arch Surg 18:1737–1762, 1929 Davidoff LM: Treatment of hydrocephalus. Historical review and description of a new method. Arch Surg 18:1737–1762, 1929
De S: A study of the changes in the brain in experimental internal hydrocephalus. J Pathol Bacteriol 62:197–208, 1950 De S: A study of the changes in the brain in experimental internal hydrocephalus. J Pathol Bacteriol 62:197–208, 1950
DeFeo DR, , Myers P, & Foltz EL, et al: Histological examination of kaolin-induced hydrocephalus. Its implications in the therapy of animals with experimentally induced hydrocephalus. J Neurosurg 50:70–74, 1979 DeFeo DR, Myers P, Foltz EL, et al: Histological examination of kaolin-induced hydrocephalus. Its implications in the therapy of animals with experimentally induced hydrocephalus. J Neurosurg 50:70–74, 1979
Derynck R, & Feng XH: TGF-β receptor signaling. Biochim Biophys Acta 1333:F105–F150, 1997 Derynck R, Feng XH: TGF-β receptor signaling. Biochim Biophys Acta 1333:F105–F150, 1997
Dixon WE, & Heller H: Experimentelle Hypertonie durch Erhöhung des intrakraniellen Drückes. Arch Exp Pathol Pharmakol 166:265–275, 1932 Dixon WE, Heller H: Experimentelle Hypertonie durch Erhöhung des intrakraniellen Drückes. Arch Exp Pathol Pharmakol 166:265–275, 1932
Dohrmann GJ: Cervical spinal cord in experimental hydrocephalus. J Neurosurg 37:538–542, 1972 Dohrmann GJ: Cervical spinal cord in experimental hydrocephalus. J Neurosurg 37:538–542, 1972
Eckstein HB, & Macnab GH: Myelomeningocele and hydrocephalus. The impact of modern treatment. Lancet 1:842–845, 1966 Eckstein HB, Macnab GH: Myelomeningocele and hydrocephalus. The impact of modern treatment. Lancet 1:842–845, 1966
Edwards MS, , Harrison MR, & Halks-Miller M, et al: Kaolininduced congenital hydrocephalus in utero in fetal lambs and rhesus monkeys. J Neurosurg 60:115–122, 1984 Edwards MS, Harrison MR, Halks-Miller M, et al: Kaolininduced congenital hydrocephalus in utero in fetal lambs and rhesus monkeys. J Neurosurg 60:115–122, 1984
Ehrhart E, , Segarini P, & Tsang ML, et al: Latent transforming growth factor β1 activation in situ: quantitative and functional evidence after low-dose gamma irradiation. FASEB J 11:991–1002, 1997 Ehrhart E, Segarini P, Tsang ML, et al: Latent transforming growth factor β1 activation in situ: quantitative and functional evidence after low-dose gamma irradiation. FASEB J 11:991–1002, 1997
Eisenberg HM, , McLennan JE, & Welch K: Ventricular perfusion in cats with kaolin-induced hydrocephalus. J Neurosurg 41:20–28, 1974 Eisenberg HM, McLennan JE, Welch K: Ventricular perfusion in cats with kaolin-induced hydrocephalus. J Neurosurg 41:20–28, 1974
El-Sakka AI, , Hassoba HM, & Chui RM, et al: An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol 158:2284–2290, 1997 El-Sakka AI, Hassoba HM, Chui RM, et al: An animal model of Peyronie's-like condition associated with an increase of transforming growth factor beta mRNA and protein expression. J Urol 158:2284–2290, 1997
El-Sakka AI, , Hassoba HM, & Pillarisetty RJ, et al: Peyronie's disease is associated with an increase in transforming growth factor-β protein expression. J Urol 158:1391–1394, 1997 El-Sakka AI, Hassoba HM, Pillarisetty RJ, et al: Peyronie's disease is associated with an increase in transforming growth factor-β protein expression. J Urol 158:1391–1394, 1997
Erlebacher A, & Derynck R: Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132:195–210, 1996 Erlebacher A, Derynck R: Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132:195–210, 1996
Flanders KC, , Lucecke G, & Engels S, et al: Localization and actions of transforming growth factor—βs in the embryonic nervous system. Development 113:183–191, 1991 Flanders KC, Lucecke G, Engels S, et al: Localization and actions of transforming growth factor—βs in the embryonic nervous system. Development 113:183–191, 1991
Flanders KC, , Ren RF, & Lippa CF: Transforming growth factor-βs in neurodegenerative disease. Prog Neurobiol 54:71–85, 1998 Flanders KC, Ren RF, Lippa CF: Transforming growth factor-βs in neurodegenerative disease. Prog Neurobiol 54:71–85, 1998
Flexner S: Experimental cerebro-spinal meningitis in monkeys. J Exp Med 9:142–167, 1907 Flexner S: Experimental cerebro-spinal meningitis in monkeys. J Exp Med 9:142–167, 1907
Foltz E, , Blanks J, & Morton ME: Experimental transcerebral fistula. Perineural olfactory CSF flow in the normal, hydrocephalic, and postoperative hydrocephalic dog shown by radionuclide ventriculography. J Neurosurg 61:355–364, 1984 Foltz E, Blanks J, Morton ME: Experimental transcerebral fistula. Perineural olfactory CSF flow in the normal, hydrocephalic, and postoperative hydrocephalic dog shown by radionuclide ventriculography. J Neurosurg 61:355–364, 1984
Foster L, , Kozak K, & Loftus M, et al: The polymerase chain reaction and its application to filamentous fungi. Mycol Res 97:769–781, 1993 Foster L, Kozak K, Loftus M, et al: The polymerase chain reaction and its application to filamentous fungi. Mycol Res 97:769–781, 1993
Galbreath E, , Kim SJ, & Park K, et al: Overexpression of TGF-β1 in the central nervous system of transgenic mice results in hydrocephalus. J Neuropathol Exp Neurol 54:339–349, 1995 Galbreath E, Kim SJ, Park K, et al: Overexpression of TGF-β1 in the central nervous system of transgenic mice results in hydrocephalus. J Neuropathol Exp Neurol 54:339–349, 1995
Gold LI, , Sung JJ, & Siebert JW, et al: Type I (RI) and Type II (RII) receptors for transforming growth factor-β isoforms are expressed subsequent to transforming growth factor-β ligands during excisional wound healing. Am J Pathol 150:209–222, 1997 Gold LI, Sung JJ, Siebert JW, et al: Type I (RI) and Type II (RII) receptors for transforming growth factor-β isoforms are expressed subsequent to transforming growth factor-β ligands during excisional wound healing. Am J Pathol 150:209–222, 1997
Gonzalez-Darder J, , Barbera J, & Cerda-Nicolas M, et al: Sequential morphological and functional changes in kaolin-induced hydrocephalus. J Neurosurg 61:918–924, 1984 Gonzalez-Darder J, Barbera J, Cerda-Nicolas M, et al: Sequential morphological and functional changes in kaolin-induced hydrocephalus. J Neurosurg 61:918–924, 1984
Grande JP: Role of transforming growth factor-β in tissue injury and repair. Proc Soc Exp Biol Med 214:27–40, 1997 Grande JP: Role of transforming growth factor-β in tissue injury and repair. Proc Soc Exp Biol Med 214:27–40, 1997
Grande JP, , Melder DC, & Zinsmeister AR: Modulation of collagen gene expression by cytokines: stimulatory effect of transforming growth factor-β1, with divergent effects of epidermal growth factor and tumor necrosis factor α on collagen type I and collagen type IV. J Lab Clin Med 130:476–486, 1997 Grande JP, Melder DC, Zinsmeister AR: Modulation of collagen gene expression by cytokines: stimulatory effect of transforming growth factor-β1, with divergent effects of epidermal growth factor and tumor necrosis factor α on collagen type I and collagen type IV. J Lab Clin Med 130:476–486, 1997
Griffith J, , Jeffers WA, & Lindauer M: A study of the mechanism of hypertension following intracisternal kaolin injection in rats. Leucocytic reaction and effect on lymphatic absorption. Am J Physiol 113:285–290, 1935 Griffith J, Jeffers WA, Lindauer M: A study of the mechanism of hypertension following intracisternal kaolin injection in rats. Leucocytic reaction and effect on lymphatic absorption. Am J Physiol 113:285–290, 1935
Griffith J, & Roberts E: Further studies in the mechanism of vascular hypertension following the intracisternal injection of kaolin in the rat. Am J Physiol 124:86–93, 1938 Griffith J, Roberts E: Further studies in the mechanism of vascular hypertension following the intracisternal injection of kaolin in the rat. Am J Physiol 124:86–93, 1938
Haralson MA: Transforming growth factor—β, other growth factors, and the extracellular matrix. J Lab Clin Med 130:455–458, 1997 Haralson MA: Transforming growth factor—β, other growth factors, and the extracellular matrix. J Lab Clin Med 130:455–458, 1997
Heine U, , Munoz E, & Flanders K, et al: Role of transforming growth factor-β1 in the development of the mouse embryo. J Cell Biol 105:2861–2876, 1987 Heine U, Munoz E, Flanders K, et al: Role of transforming growth factor-β1 in the development of the mouse embryo. J Cell Biol 105:2861–2876, 1987
Heldin CH, , Miyazono K, & ten Dijke P: TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465–471, 1997 Heldin CH, Miyazono K, ten Dijke P: TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465–471, 1997
Hirayama A: Histopathological study of congenital and acquired experimental hydrocephalus. Brain Dev 2:171–189, 1980 Hirayama A: Histopathological study of congenital and acquired experimental hydrocephalus. Brain Dev 2:171–189, 1980
Hochwald GM: Animal models of hydrocephalus: recent developments. Proc Soc Exp Biol Med 178:1–11, 1985 Hochwald GM: Animal models of hydrocephalus: recent developments. Proc Soc Exp Biol Med 178:1–11, 1985
Hochwald GM, , Epstein F, & Malhan C, et al: The relationship of compensated to decompensated hydrocephalus in the cat. J Neurosurg 39:694–697, 1973 Hochwald GM, Epstein F, Malhan C, et al: The relationship of compensated to decompensated hydrocephalus in the cat. J Neurosurg 39:694–697, 1973
Hochwald GM, , Epstein F, & Malhan C, et al: The role of the skull and dura in experimental feline hydrocephalus. Dev Med Child Neurol 14:65–69, 1972 Hochwald GM, Epstein F, Malhan C, et al: The role of the skull and dura in experimental feline hydrocephalus. Dev Med Child Neurol 14:65–69, 1972
Hochwald GM, , Lux WE Jr, & Sahar A, et al: Experimental hydrocephalus. Changes in cerebrospinal fluid dynamics as a function of time. Arch Neurol 26:120–129, 1972 Hochwald GM, Lux WE Jr, Sahar A, et al: Experimental hydrocephalus. Changes in cerebrospinal fluid dynamics as a function of time. Arch Neurol 26:120–129, 1972
Hochwald GM, , Sahar A, & Sadik, AR, et al: Cerebrospinal fluid production and histological observations in animals with experimental obstructive hydrocephalus. Exp Neurol 25:190–199, 1969 Hochwald GM, Sahar A, Sadik, AR, et al: Cerebrospinal fluid production and histological observations in animals with experimental obstructive hydrocephalus. Exp Neurol 25:190–199, 1969
Ichiyama T, , Hayashi T, & Nishikawa M, et al: Levels of transforming growth factor β1, tumor necrosis factor α, and interleukin 6 in cerebrospinal fluid: association with clinical outcome for children with bacterial meningitis. Clin Infect Dis 25:328–329, 1997 Ichiyama T, Hayashi T, Nishikawa M, et al: Levels of transforming growth factor β1, tumor necrosis factor α, and interleukin 6 in cerebrospinal fluid: association with clinical outcome for children with bacterial meningitis. Clin Infect Dis 25:328–329, 1997
James AE Jr, & Strecker EP: Use of silastic to produce communicating hydrocephalus. Invest Radiol 8:105–110, 1973 James AE Jr, Strecker EP: Use of silastic to produce communicating hydrocephalus. Invest Radiol 8:105–110, 1973
Jhappan C, , Geiser AG, & Kordon EC, et al: Targeting expression of a transforming growth factor β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J 12:1835–1845, 1993 Jhappan C, Geiser AG, Kordon EC, et al: Targeting expression of a transforming growth factor β1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J 12:1835–1845, 1993
Johnson MD, , Gold LI, & Moses HL: Evidence for transforming growth factor-β expression in human leptomeningeal cells and transforming growth factor-β-like activity in human cerebrospinal fluid. Lab Invest 67:360–368, 1992 Johnson MD, Gold LI, Moses HL: Evidence for transforming growth factor-β expression in human leptomeningeal cells and transforming growth factor-β-like activity in human cerebrospinal fluid. Lab Invest 67:360–368, 1992
Johnson RT, & Johnson KP: Hydrocephalus as a sequela of experimental myxovirus infections. Exp Mol Pathol 10:68–80, 1969 Johnson RT, Johnson KP: Hydrocephalus as a sequela of experimental myxovirus infections. Exp Mol Pathol 10:68–80, 1969
Johnson RT, & Johnson KP: Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol 27:591–606, 1968 Johnson RT, Johnson KP: Hydrocephalus following viral infection: the pathology of aqueductal stenosis developing after experimental mumps virus infection. J Neuropathol Exp Neurol 27:591–606, 1968
Johnson RT, , Johnson KP, & Edmonds CJ: Virus-induced hydrocephalus: development of aqueductal stenosis in hamsters after mumps infection. Science 157:1066–1067, 1967 Johnson RT, Johnson KP, Edmonds CJ: Virus-induced hydrocephalus: development of aqueductal stenosis in hamsters after mumps infection. Science 157:1066–1067, 1967
Jones HC, & Bucknall RM: Inherited prenatal hydrocephalus in the H-Tx rat: a morphological study. Neuropathol Appl Neurobiol 14:263–274, 1988 Jones HC, Bucknall RM: Inherited prenatal hydrocephalus in the H-Tx rat: a morphological study. Neuropathol Appl Neurobiol 14:263–274, 1988
Jones HC, , Harris NG, & Briggs RW, et al: Shunt treatment at two postnatal ages in hydrocephalic H-Tx rats quantified using MR imaging. Exp Neurol 133:144–152, 1995 Jones HC, Harris NG, Briggs RW, et al: Shunt treatment at two postnatal ages in hydrocephalic H-Tx rats quantified using MR imaging. Exp Neurol 133:144–152, 1995
Jones HC, , Harris NG, & Inglis BA, et al: Reduced cortical metabolites are avoided by early shunt-treatment in congenitally hydrocephalic rats. J Cereb Blood Flow Metab 15 (Suppl 1):S585, 1995 (Abstract) Jones HC, Harris NG, Inglis BA, et al: Reduced cortical metabolites are avoided by early shunt-treatment in congenitally hydrocephalic rats. J Cereb Blood Flow Metab 15 (Suppl 1):S585, 1995 (Abstract)
Jones HC, , Richards HK, & Bucknall RM, et al: Local cerebral blood flow in rats with congenital hydrocephalus. J Cereb Blood Flow Metab 13:531–534, 1993 Jones HC, Richards HK, Bucknall RM, et al: Local cerebral blood flow in rats with congenital hydrocephalus. J Cereb Blood Flow Metab 13:531–534, 1993
Kitazawa K, & Tada T: Elevation of transforming growth factor β-1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage. Stroke 25:1400–1404, 1994 Kitazawa K, Tada T: Elevation of transforming growth factor β-1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage. Stroke 25:1400–1404, 1994
Kopp JB, , Factor VM, & Mozes M, et al: Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 74:991–1003, 1996 Kopp JB, Factor VM, Mozes M, et al: Transgenic mice with increased plasma levels of TGF-β1 develop progressive renal disease. Lab Invest 74:991–1003, 1996
Kriegelstein K, , Rufer M, & Suter-Crazzolara C, et al: Neural functions of the transforming growth factor β. Int J Dev Neurosci 13:301–315, 1995 Kriegelstein K, Rufer M, Suter-Crazzolara C, et al: Neural functions of the transforming growth factor β. Int J Dev Neurosci 13:301–315, 1995
Krupinski J, , Kumar P, & Kumar S, et al: Increased expression of TGF-β1 in brain tissue after ischemic stroke in humas. Stroke 27:852–857, 1996 Krupinski J, Kumar P, Kumar S, et al: Increased expression of TGF-β1 in brain tissue after ischemic stroke in humas. Stroke 27:852–857, 1996
Kulkarni AB, , Huh CG, & Becker D, et al: Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770–774, 1993 Kulkarni AB, Huh CG, Becker D, et al: Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA 90:770–774, 1993
Kumar AJ, , Hochwald GM, & Kricheff I, et al: Positive contrast ventriculography in cats with experimental obstructive hydrocephalus. Invest Radiol 11:605–611, 1976 Kumar AJ, Hochwald GM, Kricheff I, et al: Positive contrast ventriculography in cats with experimental obstructive hydrocephalus. Invest Radiol 11:605–611, 1976
Kuruvilla A, , Shah R, & Hochwald GM, et al: Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 88:2918–2921, 1991 Kuruvilla A, Shah R, Hochwald GM, et al: Protective effect of transforming growth factor β1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 88:2918–2921, 1991
Laurence KM, & Coates S: The natural history of hydrocephalus. Detailed analysis of 182 unoperated cases. Arch Dis Child 37:345–362, 1962 Laurence KM, Coates S: The natural history of hydrocephalus. Detailed analysis of 182 unoperated cases. Arch Dis Child 37:345–362, 1962
Lee MS, , Gu D, & Feng L, et al: Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor beta 1. Am J Pathol 147:42–52, 1995 Lee MS, Gu D, Feng L, et al: Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor beta 1. Am J Pathol 147:42–52, 1995
Letterio JJ, , Geiser AG, & Kulkarni AB, et al: Maternal rescue of transforming growth factor-β1 null mice. Science 264:1936–1938, 1994 Letterio JJ, Geiser AG, Kulkarni AB, et al: Maternal rescue of transforming growth factor-β1 null mice. Science 264:1936–1938, 1994
Logan A, & Berry M: Transforming growth factor-β1 and basic fibroblast growth factor in the injured CNS. Trends Pharmacol Sci 14:337–342, 1993 Logan A, Berry M: Transforming growth factor-β1 and basic fibroblast growth factor in the injured CNS. Trends Pharmacol Sci 14:337–342, 1993
Logan A, , Berry M, & Gonzalez AM, et al: Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur J Neurosci 6:355–363, 1994 Logan A, Berry M, Gonzalez AM, et al: Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur J Neurosci 6:355–363, 1994
Lovely TJ, , McAllister JP II, & Miller DW, et al: Effects of hydrocephalus and surgical decompression on cortical norepinephrine levels in neonatal rats. Neurosurgery 24:43–52, 1989 Lovely TJ, McAllister JP II, Miller DW, et al: Effects of hydrocephalus and surgical decompression on cortical norepinephrine levels in neonatal rats. Neurosurgery 24:43–52, 1989
Margolis G, & Kilham L: Induction of congenital hydrocephalus in hamsters with parainfluenza type 2 virus. Exp Mol Pathol 27:235–248, 1977 Margolis G, Kilham L: Induction of congenital hydrocephalus in hamsters with parainfluenza type 2 virus. Exp Mol Pathol 27:235–248, 1977
Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 6:597–641, 1990 Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 6:597–641, 1990
Masters C, , Alpers M, & Kakulas B: Pathogenesis of reovirus type 1 hydrocephalus in mice. Significance of aqueductal changes. Arch Neurol 34:18–28, 1977 Masters C, Alpers M, Kakulas B: Pathogenesis of reovirus type 1 hydrocephalus in mice. Significance of aqueductal changes. Arch Neurol 34:18–28, 1977
McAllister JP II, , Cohen MI, & O'Mara KA, et al: Progression of experimental infantile hydrocephalus and effects of ventriculoperitoneal shunts: an analysis correlating magnetic resonance imaging with gross morphology. Neurosurgery 29:329–340, 1991 McAllister JP II, Cohen MI, O'Mara KA, et al: Progression of experimental infantile hydrocephalus and effects of ventriculoperitoneal shunts: an analysis correlating magnetic resonance imaging with gross morphology. Neurosurgery 29:329–340, 1991
Milhorat TH: Experimental hydrocephalus.1: A technique for producing obstructive hydrocephalus in the monkey. J Neurosurg 32:385–389, 1970 Milhorat TH: Experimental hydrocephalus.1: A technique for producing obstructive hydrocephalus in the monkey. J Neurosurg 32:385–389, 1970
Milhorat TH: Hydrocephalus: pathophysiology and clinical features, in Wilkins RH, & Rengachary SS (eds): Neurosurgery. New York: McGraw-Hill, 1996, Vol 3, pp 3625–3631 Milhorat TH: Hydrocephalus: pathophysiology and clinical features, in Wilkins RH, Rengachary SS (eds): Neurosurgery. New York: McGraw-Hill, 1996, Vol 3, pp 3625–3631
Nigam R, & Singhal SL: Hydrocephalus—experimental observations. Indian J Surg 21:12–20, 1959 Nigam R, Singhal SL: Hydrocephalus—experimental observations. Indian J Surg 21:12–20, 1959
Nulsen FE, & Spitz EB: Treatment of hydrocephalus by direct shunt from ventricle to jugular vein. Surg Forum 2:399–403, 1952 Nulsen FE, Spitz EB: Treatment of hydrocephalus by direct shunt from ventricle to jugular vein. Surg Forum 2:399–403, 1952
Peacock W: Prevention and management of cerebrospinal fluid shunt complications. Prog Neurol Surg 13:114–130, 1990 Peacock W: Prevention and management of cerebrospinal fluid shunt complications. Prog Neurol Surg 13:114–130, 1990
Pople IK, , Quinn MW, & Bayston R: Morbidity and outcome of shunted hydrocephalus. Z Kinderchir 45 (Suppl 1):29–31, 1990 Pople IK, Quinn MW, Bayston R: Morbidity and outcome of shunted hydrocephalus. Z Kinderchir 45 (Suppl 1):29–31, 1990
Pudenz RH, & Foltz EL: Hydrocephalus: overdrainage by ventricular shunts. A review and recommendations. Surg Neurol 35:200–212, 1991 Pudenz RH, Foltz EL: Hydrocephalus: overdrainage by ventricular shunts. A review and recommendations. Surg Neurol 35:200–212, 1991
Raghow R: The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 8:823–831, 1994 Raghow R: The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 8:823–831, 1994
Raimondi AJ, , Clark SJ, & McLone DG: Pathogenesis of aqueductal occlusion in congenital murine hydrocephalus. J Neurosurg 45:66–77, 1976 Raimondi AJ, Clark SJ, McLone DG: Pathogenesis of aqueductal occlusion in congenital murine hydrocephalus. J Neurosurg 45:66–77, 1976
Roberts AB, , Anzano MA, & Lamb LC, et al: New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 78:5339–5343, 1981 Roberts AB, Anzano MA, Lamb LC, et al: New class of transforming growth factors potentiated by epidermal growth factor: isolation from non-neoplastic tissues. Proc Natl Acad Sci USA 78:5339–5343, 1981
Rollnick JD, , Sindern E, & Schweppe C, et al: Biologically active TGF-β1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patients. Acta Neurol Scand 96:101–105, 1997 Rollnick JD, Sindern E, Schweppe C, et al: Biologically active TGF-β1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patients. Acta Neurol Scand 96:101–105, 1997
Roth P, & Cohen AR: Management of hydrocephalus in infants and children, in Tindall GT, , Cooper PR, & Barrow DL (eds): The Practice of Neurosurgery. Baltimore: Williams & Wilkins, 1996, pp 2707–2728 Roth P, Cohen AR: Management of hydrocephalus in infants and children, in Tindall GT, Cooper PR, Barrow DL (eds): The Practice of Neurosurgery. Baltimore: Williams & Wilkins, 1996, pp 2707–2728
Rubin RC, , Hochwald GM, & Tiell M, et al: Hydrocephalus I: histological and ultrastructural changes in the pre-shunted cortical mantle. Surg Neurol 5:109–114, 1976 Rubin RC, Hochwald GM, Tiell M, et al: Hydrocephalus I: histological and ultrastructural changes in the pre-shunted cortical mantle. Surg Neurol 5:109–114, 1976
Rubin RC, , Hochwald GM, & Tiell M, et al: Hydrocephalus II: cell number and size, and myelin content of the pre-shunted cerebral cortical mantle. Surg Neurol 5:115–118, 1976 Rubin RC, Hochwald GM, Tiell M, et al: Hydrocephalus II: cell number and size, and myelin content of the pre-shunted cerebral cortical mantle. Surg Neurol 5:115–118, 1976
Sanderson N, , Factor V, & Nagy P, et al: Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2572–2576, 1995 Sanderson N, Factor V, Nagy P, et al: Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2572–2576, 1995
Schurr PH, , McLaurin RL, & Ingraham FD: Experimental studies on the circulation of the cerebrospinal fluid and methods of producing communicating hydrocephalus in the dog. J Neurosurg 10:515–525, 1953 Schurr PH, McLaurin RL, Ingraham FD: Experimental studies on the circulation of the cerebrospinal fluid and methods of producing communicating hydrocephalus in the dog. J Neurosurg 10:515–525, 1953
Sellheyer K, , Bickenbach JR, & Rothnagel JA, et al: Inhibition of skin development by overexpression of transforming growth factor β1 in the epidermis of transgenic mice. Proc Natl Acad Sci USA 90:5237–5241, 1993 Sellheyer K, Bickenbach JR, Rothnagel JA, et al: Inhibition of skin development by overexpression of transforming growth factor β1 in the epidermis of transgenic mice. Proc Natl Acad Sci USA 90:5237–5241, 1993
Shah M, , Foreman DM, & Ferguson MW: Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 108:985–1002, 1995 Shah M, Foreman DM, Ferguson MW: Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci 108:985–1002, 1995
Shull MM, , Ormsby I, & Kier AB, et al: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693–699, 1992 Shull MM, Ormsby I, Kier AB, et al: Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693–699, 1992
Tada T, , Kanaji M, & Kobayashi S: Induction of communicating hydrocephalus in mice by intrathecal injection of human recombinant transforming growth factor-β1. J Immunol 50:153–158, 1994 Tada T, Kanaji M, Kobayashi S: Induction of communicating hydrocephalus in mice by intrathecal injection of human recombinant transforming growth factor-β1. J Immunol 50:153–158, 1994
Van der Waal EA, , Gomez-Pinilla F, & Cotman CW: Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies. Neuroreport 4:69–72, 1993 Van der Waal EA, Gomez-Pinilla F, Cotman CW: Transforming growth factor-β1 is in plaques in Alzheimer and Down pathologies. Neuroreport 4:69–72, 1993
Vawter MP, , Dillon-Carter O, & Issa F, et al: Transforming growth factors β1 and β2 in the cerebrospinal fluid of chronic schizophrenic patients. Neuropsychopharmacology 16:83–87, 1997 Vawter MP, Dillon-Carter O, Issa F, et al: Transforming growth factors β1 and β2 in the cerebrospinal fluid of chronic schizophrenic patients. Neuropsychopharmacology 16:83–87, 1997
Vawter MP, , Dillon-Carter O, & Tourtellotte WW, et al: TGFβ1 and TGFβ2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Exp Neurol 142:313–322, 1996 Vawter MP, Dillon-Carter O, Tourtellotte WW, et al: TGFβ1 and TGFβ2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Exp Neurol 142:313–322, 1996
Wahl SM, , Allen JB, & McCartney-Francis N, et al: Macrophageand astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immunodeficiency syndrome. J Exp Med 173:981–991, 1991 Wahl SM, Allen JB, McCartney-Francis N, et al: Macrophageand astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immunodeficiency syndrome. J Exp Med 173:981–991, 1991
Weller RO, & Wisniewski H: Histological and ultrastructural changes with experimental hydrocephalus in adult rats. Brain 92:819–828, 1969 Weller RO, Wisniewski H: Histological and ultrastructural changes with experimental hydrocephalus in adult rats. Brain 92:819–828, 1969
Wislocki GB, & Putnam TJ: Absorption from the ventricles in experimentally produced internal hydrocephalus. Am J Anat 29:313–320, 1921 Wislocki GB, Putnam TJ: Absorption from the ventricles in experimentally produced internal hydrocephalus. Am J Anat 29:313–320, 1921
Wolfson BJ, , McAllister JP II, & Lovely TJ, et al: Sonographic evaluation of experimental hydrocephalus in kittens. AJNR 10:1065–1067, 1989 Wolfson BJ, McAllister JP II, Lovely TJ, et al: Sonographic evaluation of experimental hydrocephalus in kittens. AJNR 10:1065–1067, 1989
Wrana JL, , Attisano L, & Wieser R, et al: Mechanism of activation of the TGF-β receptor. Nature 370:341–347, 1994 Wrana JL, Attisano L, Wieser R, et al: Mechanism of activation of the TGF-β receptor. Nature 370:341–347, 1994
Wyss-Coray T, , Feng L, & Masliah E, et al: Increase central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1. Am J Pathol 147:53–67, 1995 Wyss-Coray T, Feng L, Masliah E, et al: Increase central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1. Am J Pathol 147:53–67, 1995
Yamaguchi Y, , Mann DM, & Ruoslahti E: Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346:281–284, 1990 Yamaguchi Y, Mann DM, Ruoslahti E: Negative regulation of transforming growth factor-β by the proteoglycan decorin. Nature 346:281–284, 1990
Yashon D, , Jane JA, & Sugar O: The course of severe untreated infantile hydrocephalus. Prognostic significance of the cerebral mantle. J Neurosurg 23:509–516, 1965 Yashon D, Jane JA, Sugar O: The course of severe untreated infantile hydrocephalus. Prognostic significance of the cerebral mantle. J Neurosurg 23:509–516, 1965
Yoon CH, & Slaney J: Hydrocephalus: a new mutation in the Syrian golden hamster. J Hered 63:344–346, 1972 Yoon CH, Slaney J: Hydrocephalus: a new mutation in the Syrian golden hamster. J Hered 63:344–346, 1972
Yoshimoto T, , Houkin K, & Takahashi A, et al: Evaluation of cytokines in cerebrospinal fluid from patients with Moyamoya disease. Clin Neurol Neurosurg 99 (Suppl 2):S218–S220, 1997 Yoshimoto T, Houkin K, Takahashi A, et al: Evaluation of cytokines in cerebrospinal fluid from patients with Moyamoya disease. Clin Neurol Neurosurg 99 (Suppl 2):S218–S220, 1997
Zhang K, , Flanders KC, & Phan SH: Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am J Pathol 147:352–361, 1995 Zhang K, Flanders KC, Phan SH: Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am J Pathol 147:352–361, 1995
| All Time | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 489 | 143 | 7 |
| Full Text Views | 240 | 26 | 0 |
| PDF Downloads | 154 | 20 | 0 |
| EPUB Downloads | 0 | 0 | 0 |